ExecRoster

Fractional CRO for Healthtech Companies: When to Hire One

November 20, 20266 min read

A fractional CRO for healthtech companies is a part-time revenue leader who builds a sales system for committee buyers: health systems, payers, provider groups and employers. They map the buying process, structure pilots that convert, tie sales to implementation and give the board a forecast it can believe. Most companies hire one once founder-led selling stops scaling.

Why selling healthtech is its own discipline

General software sales playbooks break in healthcare, for reasons a revenue leader must plan around.

  • The user, the champion and the budget holder are different people. A nurse manager loves the product, a physician leader sponsors it, and the money sits with a service line executive or the finance office.
  • Several groups can stop a deal. IT, information security, compliance, legal, procurement and sometimes a value analysis committee each run their own review.
  • Integration is part of the sale. If the product needs data from the electronic health record, the buyer's integration team has a queue, and your deal waits in it.
  • Budget cycles are rigid. Miss the planning window at a health system and the purchase can slide a full fiscal year.
  • Signed does not mean live. Revenue, references and renewals depend on go-live and adoption, which can trail the contract by months.
  • Claims are constrained. What sales can say about clinical outcomes, and how patient data is handled, has regulatory weight. (This article is educational and not legal or regulatory advice.)

A fractional CRO with healthcare experience has run this process before and knows which steps can be run in parallel and which cannot be rushed.

What a fractional CRO actually does in a healthtech company

Chooses the segment and the buyer

Early healthtech companies often sell to anyone who will take a meeting: a large academic medical center, a regional payer, a physician group and a self-insured employer, all in the same quarter. Each has a different contract, proof requirement and sales cycle. The CRO picks the one or two segments where the product has evidence and where cycles are short enough to fund the company, then writes the qualification standard that keeps reps out of the rest.

Builds a mutual action plan for committee deals

Instead of a pipeline stage called "evaluation," the CRO writes stages around what the buyer's organization has to do. A healthtech deal plan typically lists:

  1. Clinical or operational sponsor confirmed, with the problem stated in their words.
  2. Economic buyer identified and the budget source named (operating, capital, grant or innovation fund).
  3. Security questionnaire submitted and review scheduled.
  4. Business associate agreement and contract redlines started with legal.
  5. Integration scope agreed with the buyer's IT team, with a named analyst.
  6. Business case reviewed with finance.
  7. Committee or board approval date on the calendar.
  8. Implementation kickoff date and go-live target.

Each line has an owner and a date on both sides. A deal with no security review scheduled is not in late stage, whatever the champion says.

Fixes pilots that never convert

Free or cheap pilots are a familiar trap in this market. The CRO rewrites the pilot agreement so it names success criteria in advance, the data both sides will use to judge them, a decision date, the decision maker and the commercial terms that apply if the criteria are met. A pilot without a pre-agreed path to a contract is a long unpaid implementation.

Builds the proof package

Healthcare buyers ask for evidence before they ask for a price. The CRO works with product and clinical leads to assemble what the committee will need: an outcomes or ROI model the buyer's finance team can check with their own inputs, security and compliance documentation, an integration overview, and references at similar organizations. Marketing claims get reviewed with compliance before they reach a slide.

Connects sales to implementation and renewal

The CRO tracks contracted revenue, live revenue and the backlog between them as separate numbers, and sits in a weekly review with the implementation lead. They also set up expansion plays, because some of the least costly growth in healthtech is the second department, the next facility or the next line of business inside a customer that has already passed security review.

Healthtech revenue metrics worth tracking

MetricWhy it matters in healthtech
Sales cycle by segmentA physician group and a health system should never be averaged together
Pilot-to-contract conversionShows whether pilots are a sales step or a dead end
Days in security and legal reviewA stage where deals often stall, and one you can prepare for
Contract signature to go-liveDetermines when revenue and references actually arrive
Contracted versus live recurring revenueReveals implementation backlog hiding inside bookings
Adoption at 90 days after go-liveThe earliest signal of renewal risk
Expansion within existing accountsAdditional sites or departments, sold without a new security review
Forecast accuracy by quarterBoards lose patience quickly with deals that slip three quarters running

Signs it is time to hire one

  • The founder is still the only person who can close, and the calendar is full.
  • You have several pilots running and none has a signed conversion date.
  • Deals reach verbal yes and then sit in security, legal or procurement for months.
  • The forecast slips every quarter and the board has started discounting it.
  • You hired experienced software reps and they are struggling with clinical buyers.
  • Signed contracts are piling up waiting for implementation.
  • You are moving from one buyer type to another, such as from provider groups to payers or employers.
  • A funding round is coming and you need a credible pipeline story.
  • You cannot yet justify, or attract, a full-time revenue executive with healthcare depth.

How the engagement is usually shaped

Healthtech cycles are long, so the engagement should be too. A short sprint will end before the deals it influenced can close.

  • Weeks one to four: diagnostic. Deal-by-deal pipeline review, win and loss interviews with a handful of buyers, an audit of pilot agreements, and a written plan naming target segments and the top constraints.
  • Months two to four: build. Stage definitions and the mutual action plan template, the proof package, a pilot agreement standard, pricing and contracting guidelines, and the weekly sales and implementation review.
  • Month four onward: run and hire. Weekly forecast and deal reviews, coaching reps through committee meetings, board reporting, and recruiting the first sales manager or full-time successor when the model supports one.

Two days a week is common in the build phase, tapering as a manager takes over daily deal work. Agree up front which executive meetings with buyers the CRO will attend in person, since senior presence matters in health system sales. Scope it in writing using the guide to scoping a fractional engagement, and read how to hire a fractional executive for interview questions. If you want to talk with candidates before committing, ExecRoster lets companies book time on an executive's calendar from their published profile.

When you interview, ask each candidate to walk through a health system or payer deal they ran from first meeting to go-live, naming every committee and how long each took. The detail in that answer shows whether they ran the process or watched it.

For experienced executives

Get found and hired for fractional work.

  • A profile companies can find
  • A calendar they can book
  • Paid to your bank, you keep 90%
Join the Roster Hiring? Browse the roster →

Frequently asked questions

What does a fractional CRO do for a healthtech startup?+

They pick the buyer segments worth pursuing, write deal stages around the buyer's committee process, restructure pilots so they have success criteria and a conversion date, assemble the evidence and security package buyers ask for, connect sales with implementation, and produce a forecast the board can rely on. They also coach reps and help hire the permanent sales team.

When should a healthtech company hire a fractional CRO?+

Typical signs are a founder who is the only closer, pilots with no conversion date, deals stalling in security or procurement after a verbal yes, a forecast that slips every quarter, and experienced software reps struggling with clinical buyers. It also fits when you are changing buyer type or cannot yet justify a full-time executive with healthcare experience.

How do you stop healthtech pilots from stalling?+

Write the conversion path into the pilot agreement before it starts. Name the success criteria, the data both sides will use, the decision date, the person who decides and the commercial terms that apply if criteria are met. Schedule security and legal review during the pilot, not after it, so a successful result can move straight to contract.

How long should a fractional CRO engagement last in healthtech?+

Plan for longer than a typical software engagement because health system and payer sales cycles are long. A common shape is a four-week diagnostic, about three months of building process and proof materials, then ongoing forecast, coaching and hiring work. Ending sooner usually means the engagement finishes before the deals it shaped have had time to close.

Put your experience to work.

Get on the roster, get found by companies that need exactly your background, and get paid on your terms.

Qualified, paid engagements · Your rate, your calendar · Cancel anytime

We use cookies to understand how the site is used and to measure our marketing. See our cookie policy.